Novo Nordisk Beating Lilly in Obesity Pill Market: What It Means for Investors
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesNovo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
As AI accelerates, a handful of chipmakers stand to benefit the most. This guide highlights four brilliant chip stock...
Amazon continues to trim staff in a bid to reset costs and refocus on core growth areas. This article breaks down wha...
Tokyo police have detained a senior figure tied to the Prince Group in a luxury Osaka hotel raid, tying him to a spra...
Kalshi has closed two insider trading investigations tied to a former California gubernatorial candidate and a mrbeas...
A leading robotic-assisted surgery platform maker is drawing long-term investor attention as it grows its recurring r...
U.S. regulators propose bank-style rules for stablecoin issuers, demanding AML programs, data reporting, and reserve ...
MicroStrategy's crypto treasury, dubbed Strategy, remains substantially underwater as Saylor signals another bitcoin ...
UnitedHealth Group faces headwinds that go beyond routine market cycles. This guide breaks down the challenges, what ...
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
Microsoft is recalibrating its internal AI tools as costs climb, signaling a broader shift in how AI is priced into b...
AscendEX has halted most platform services after failing to secure MiCA authorization. The firm warns withdrawals may...